Related Experiment Video

Updated: Aug 24, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities

D A Lewinsohn1, M L Gennaro, L Scholvinck

  • 1Department of Pediatrics, Oregon Health & Science University, Portland 97239, USA. lewinsde@ohsu.edu

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|May 13, 2004
PubMed

Insights

Young children face severe tuberculosis (TB) due to immune system differences, including weaker Th1 responses and stronger Th2 responses to Mycobacterium tuberculosis.

Area of Science:

  • Immunology
  • Pediatrics
  • Infectious Diseases

Background:

  • Tuberculosis (TB) is a major global infectious disease causing significant morbidity and mortality.
  • Young children are disproportionately affected by severe Mycobacterium tuberculosis infections.
  • Immune system differences between children and adults are critical to understanding pediatric TB.

Purpose of the Study:

  • To review the components of protective immunity against TB.
  • To highlight immune system differences relevant to pediatric tuberculosis.
  • To discuss M. tuberculosis-specific T-cell immunity in children and its applications.

Main Methods:

  • Review of existing knowledge on TB immunity.
  • Analysis of immune system differences in pediatric populations.
  • Examination of T-cell responses to Mycobacterium tuberculosis in children.

Main Results:

  • Children exhibit deficiencies in macrophage and dendritic cell function.
  • Infants and young children show impaired Th1-type T-cell development.
  • Children have a propensity to develop Th2-type CD4+ T-cells against immunogens.

Conclusions:

  • Immune system immaturity in children contributes to severe TB outcomes.
  • Understanding these differences is crucial for developing pediatric TB diagnostics and vaccines.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.